Hotflash Inc

Share this post

It's 'fezo' for short

hotflashinc.substack.com

It's 'fezo' for short

An epic look at Astellas Pharma's big new drug for hot flashes

Hotflash Inc
Feb 17, 2023
∙ Paid
1
7
Share

Screenshot from What’s VMS?

The first non-hormonal drug to treat hot flashes looks like it will hit the US market imminently, with approval of fezolintant anticipated as early as February 22.

If you are wondering why Japan’s Astellas Pharma can put a date on such things, I’ll tell you.

You know what to do.

Keep reading with a 7-day free trial

Subscribe to Hotflash Inc to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
Previous
Next
© 2023 Hotflash inc
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing